Avricore Health Inc. (TSXV:AVCR)

Canada flag Canada · Delayed Price · Currency is CAD
0.0700
0.00 (0.00%)
At close: Mar 9, 2026
75.00%
Market Cap 7.09M
Revenue (ttm) 1.92M
Net Income (ttm) -1.63M
Shares Out 101.29M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 77,500
Average Volume 46,909
Open 0.0700
Previous Close 0.0700
Day's Range 0.0700 - 0.0700
52-Week Range 0.0350 - 0.1000
Beta 0.31
RSI 49.00
Earnings Date Apr 28, 2026

About Avricore Health

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. [Read more]

Sector Healthcare
Founded 1996
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol AVCR
Full Company Profile

Financial Performance

In 2024, Avricore Health's revenue was 4.79 million, an increase of 37.32% compared to the previous year's 3.49 million. Losses were -668,977, -4.60% less than in 2023.

Financial Statements

News

There is no news available yet.